JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiu, X.
Right arrow Articles by Abdel-Meguid, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiu, X.
Right arrow Articles by Abdel-Meguid, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 51, 36465-36471, December 17, 1999


Crystal Structure of beta -Ketoacyl-Acyl Carrier Protein Synthase III
A KEY CONDENSING ENZYME IN BACTERIAL FATTY ACID BIOSYNTHESIS*

Xiayang QiuDagger , Cheryl A. Janson, Alex K. Konstantinidis, Silas Nwagwu, Carol Silverman, Ward W. Smith, Sanjay Khandekar, John Lonsdale, and Sherin S. Abdel-Meguid

From SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

beta -Ketoacyl-acyl carrier protein synthase III (FabH), the most divergent member of the family of condensing enzymes, is a key catalyst in bacterial fatty acid biosynthesis and a promising target for novel antibiotics. We report here the crystal structures of FabH determined in the presence and absence of acetyl-CoA. These structures display a fold that is common for condensing enzymes. The observed acetylation of Cys112 proves its catalytic role and clearly defines the primer binding pocket. Modeling based on a bound CoA molecule suggests catalytic roles for His244 and Asn274. The structures provide the molecular basis for FabH substrate specificity and reaction mechanism and are important for structure-based design of novel antibiotics.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Condensing enzymes catalyze carbon-carbon bond formation by condensing an acyl primer with an elongating carbon source often attached to a holo-acyl carrier protein (ACP).1 These enzymes act either as single polypeptides or domains of multienzyme complexes. They are responsible for the biosynthesis of a diverse set of natural products, including fatty acids (1, 2) and polyketides (3), and have recently been used to catalyze the synthesis of "unnatural" compounds (4, 5). Three condensing enzymes are involved in bacterial fatty acid biosynthesis: FabB, FabF, and FabH (beta -ketoacyl-ACP synthase I, II, and III, respectively). Each catalyzes a distinct biochemical reaction (1, 2). FabH plays a central role in fatty acid synthesis because it catalyzes the initiating condensation reaction and is responsible for the feedback regulation of the pathway via product (palmitoyl-ACP) inhibition (6-9). FabH catalyzes the condensation of acetyl-CoA and malonyl-ACP to yield acetoacetyl-ACP. The reaction is believed to occur in three steps: the acetyl transfer from acetyl-CoA to a catalytic cysteine, the decarboxylation of malonyl-ACP to form a carbanion, and the condensation of the acetyl group and carbanion (1, 2). FabH most likely acts as a homodimer of ~70 kDa (10, 11). In a similar manner to other components of the dissociated (type II) fatty acid synthase system, FabH exists as an isolated enzyme. In vertebrates, however, this enzymatic activity is encoded in the N terminus of a large multi-functional Type I fatty acid synthase, which displays no overall sequence homology to the bacterial enzyme. Emerging resistance to currently used antibacterial agents has generated an urgent need for antibiotics acting via novel mechanisms (12, 13). FabH exists ubiquitously in bacteria and is essential for viability,2 suggesting it is a potential broad-spectrum antibacterial target. Moreover, thiolactomycin has been shown to be an effective inhibitor of bacterial condensing enzymes; it also possesses antibacterial activity (1, 2). The significant differences between bacterial and human fatty acid synthase systems suggest great potential for specific and selective inhibition. Most condensing enzymes contain a consensus sequence of 45 amino acids, but FabH is the most divergent member of the family and matches few of the consensus residues (14). The antibiotic cerulenin inhibits almost all condensing enzymes but not FabH (15). Thus, FabH could have a fold and evolutionary origin different from other condensing enzymes. Here we report the crystal structure of Escherichia coli FabH in the presence and absence of ligand and show that the enzyme contains a quasi-2-fold symmetry, most likely resulting from gene duplication. The structures suggest a conserved fold for all condensing enzymes, provide the structural basis for the catalytic mechanism, and will serve as molecular templates for structure-based drug design.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Purification and Crystallization-- Native E. coli FabH protein was overexpressed in E. coli DH10B cells using the pET29 (Novagen) vector and purified to homogeneity in three chromatographic steps (Q-Sepharose, MonoQ, and hydroxyapatite) at 4 °C. The selenomethionine-substituted protein was expressed in E. coli BL21 cells and purified in a similar way. Apo FabH crystals were obtained with the native protein using 20% polyethylene glycol 8000 at neutral pH, whereas the acetyl-CoA complex crystals were obtained with the selenomethionine protein using saturating acetyl-CoA and 14% polyethylene glycol 6000 at neutral pH. Crystals were ~0.3 mm in size and were frozen before data collection.

Data Collection and Multiple-wavelength Anomalous Dispersion Phasing-- Diffraction data from the apo crystal were measured to 2.0 Å resolution at the Industrial Macromolecular Crystallography Association 17-ID beam line at the Advanced Photon Source (Table I). The crystal was of the orthorhombic P212121 space group with cell dimensions a = 63.1, b = 65.1, and c = 166.5 Å, with one FabH dimer per asymmetric unit. The selenomethionine FabH·acetyl-CoA complex crystal belongs to the tetragonal space group P41212, with a = b = 72.4 and c = 102.8 Å, and contains a monomer per asymmetric unit. The data (Table I), obtained at the X12C beam line of the Brookhaven National Laboratory, were measured at three wavelengths optimal for Se multiple-wavelength anomalous dispersion phasing experiments. Although the crystal mosaicity was as high as 1.4o (compared with that of 0.7o for the apo crystal) and the data were only 80% complete, the data quality was improved by its high redundancy. The acetyl-CoA complex structure was determined to 1.9-Å resolution using the multiple-wavelength anomalous dispersion phasing technique with the program SOLVE (16). There are 8 methionines in E. coli FabH; all were correctly located by SOLVE and refined to reasonable occupancies (0.62-1.00) and temperature factors (23 -41 Å2). The overall figure of merit was 0.6 from 30 to 1.9 Å resolutions, and the overall Z score was 148. The resulting electron density map was of very high quality (Fig. 1).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Structure determination and refinement statistics


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 1.   Experimentally (MAD) phased electron density map at Tyr125 in a cross-eye stereo view. The map is contoured at 1.5 sigma , and Tyr125 is from the refined model. The extra electron density near the main chain atoms of Tyr125 belongs to the backbone atoms of the neighboring residues.

Model Building and Refinement-- The whole FabH protein (317 residues), the bound acetyl and CoA, as well as 98 solvent molecules were built in the initial model. The data set collected at the inflection point wavelength (0.9785) (I > 2sigma [I]) were used for structural refinement with XPLOR (17) because its completion is the highest among the three. The apo FabH structure (P212121) was solved using the molecular replacement program AMORE (18) with the protein atoms from the acetyl-CoA complex structure as the search model. The two monomers were identified, and the solution gave an R-factor of 33% (8.0-3.5 Å). The model was initially built using the 2-fold averaged electron density map and refined to the final model using XPLOR. Both models (Table I) have good geometry with no Ramachandran outliers. The apo structure is clearly of good quality, as indicated by the low R-factors; the acetyl-CoA complex structure is also valid for the discussions in this report. This is because the high-quality electron density map (Fig. 1) is calculated from experimental phases; the complex structure has been used successfully to solve the apo structure; and the two structures are practically the same at alpha -carbon level (r.m.s., 0.3 Å). We have not included the Se atoms and their anomalous signal in the current stage of refinement, resulting in the slightly higher R-factors of the complex structure. The figures were created with the computer programs XTALVIEW (19), MOLSCRIPT (20), and GRASP (21).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Overall Structure: E. coli-- FabH displays a five-layered core structure, alpha -beta -alpha -beta -alpha , where each alpha  comprises two alpha -helices and each beta  is made of a five-stranded, mixed beta -sheet (Fig. 2A). Despite the lack of overall sequence homology, the FabH core structure is similar to that of FabF, the other condensing enzyme of known structure (22, 23). This fold was first identified in thiolase I, which catalyzes the degradation of ketoacyl-CoA structure (24, 25). The superposition of the FabH and FabF cores results in a r.m.s. difference of 1.7 Å for 160 pairs of alpha -carbon atoms. In the comparison, Na2, Ca2, Cb3, and part of Ca3 were excluded because of large differences. The structures beyond the cores fold into a domain for substrate recognition (Fig. 2A) and intermolecular interactions, and this domain is completely unrelated to that of FabF or thiolase. The overall sequence identity is only 14% between FabH and FabF, but the 160 pairs of structurally matched residues have a higher sequence identity of 21%, indicating that FabH is evolutionally related to FabF. Because FabF fits well with the consensus sequence (14), our results suggest a common ancestor for all condensing enzymes. Their sequences and peripheral structures have diverged significantly throughout evolution to accommodate the differences in substrates. The FabH monomer appears to have been generated through gene duplication. The two halves, residues 1-170 and 171-317, have only 11% overall sequence identity. However, their structures are similar except for the insertion and loop regions (Fig. 2B). The best matched structural elements of the two FabH halves are strands b1, b2, b4, and b5. Within these strands, the 33 pairs of alpha -carbons can be superimposed with a r.m.s. difference of only 1.0 Å, and the sequence identity between them is as high as 24%. A search of sequence data bases revealed no homologous proteins half the size of FabH, except for a few hypothetical proteins deduced from DNA sequences.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 2.   Overall structure of E. coli FabH. A, ribbon diagram of the FabH monomer. The N-terminal (1-170) and C-terminal (171-317) halves have a similar fold. The core secondary structural elements are labeled as b1-b5 and a1-a3, respectively and referred in the text with a prefix of N or C to indicate the domain they belong to. These beta -sheet and alpha -helices are drawn in magenta (N, b1-b5), cyan (N, a1-a3), red (C, b1-b5), and blue (C, a1-a3). N is the N terminus, which precedes N, b1. C is the C terminus, which comes off C, b5. Secondary elements of insertion regions are drawn in yellow and orange for N- and C-terminal domains, respectively. The catalytic Cys112 is shown in a red ball-and-stick drawing, and the CoA molecule (green) was taken from the acetyl-CoA complex structure to orient the view. B, stereo view of the superposition between the N-terminal (red) and C-terminal (blue) domains of FabH. Core beta -strands are labeled; the overlay was generated by matching the 33 alpha -carbon pairs from four of the strands.

Structure of the Dimer-- The crystal structure of FabH revealed the presence of a tight dimer (Fig. 3), consistent with our biochemical data3 and similar to the structures of FabF (22, 23) and thiolase I (24, 25). The dimer interface mainly involves Nb3, Na3, and Na2 and buries ~2670 Å2 of accessible surface area. Strand Nb3 of one monomer interacts with that of the other monomer to form a continuous 10-stranded beta -sheet in the dimer. Helix Na3, with the catalytic Cys112 near its N terminus (Gly114), uses its C-terminal half to interact with its counterpart from the other monomer. This suggests that the dimer interface is important for positioning the catalytic apparatus of FabH. The two active sites, facing opposite sides in the dimer, are formed mostly by residues within each monomer. However, Phe87 (in a loop preceding helix Na2) of one monomer projects into the active site of the other monomer. These structural features suggest that the observed dimer is the biologically relevant structure, and that its formation is essential for the proper functioning of the FabH enzyme.


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 3.   Ribbon diagram of the FabH dimer. The dimer is viewed perpendicular to the two-fold axis. One monomer is shown in yellow and green; the other is shown in cyan and magenta. Phe87 and Cys112 (red) are shown as ball-and-stick models.

Catalytic Residues-- Each FabH active site, located at the center of the monomer, is formed at the interface of the N- and C-terminal domains (Fig. 2A). The catalytic residues in thiolase I were proposed to be Cys125, His375, and Cys403 (24, 25), whereas those in FabF were predicted to be Cys163, His303, and His340 (22, 23). The corresponding residues in FabH were found by structural alignment to be Cys112, His244, and Asn274. Although FabH Cys112 aligns well with Cys163 of FabF and Cys125 of thiolase I, the structural superposition revealed significant differences among other catalytic residues (Fig. 4). The lack of a Cys403-like residue in FabH implies a role for that residue that is relevant only to the thiolase reaction. Asn274 superimposes well with the histidines in FabF (His340) and thiolase I (His375), but His244 is far from its counterpart (His303) in FabF, suggesting different substrate specificity. A previously unsuspected thiolase residue, Asn343, is found near His244 of FabH. If Asn343 plays a role in catalysis, it is possible that the His-Asn pairs of FabH and thiolase are inverted structurally to match the reversed reactions they catalyze.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 4.   Superposition of potential catalytic residues in FabH (red), FabF (blue), and thiolase I (yellow). FabH residues are labeled. The corresponding residues in FabF are Cys163, His303, and His340, and those in thiolase are Cys125, Asn343, His375, and Cys403. Thiolase Asn343 and Cys403 are labeled in parentheses.

Substrate or Ligand Binding-- Both FabF and thiolase I structures were determined in the absence of a substrate; thus, the structural basis for catalysis and substrate specificity has not been established. To further investigate these important questions, we co-crystallized FabH with its first substrate, acetyl-CoA. The overall structure of FabH in the acetyl-CoA complex agrees well with the apo structure, with a r.m.s. difference of 0.3 Å for all 317 alpha -carbons. The electron density reveals a covalent attachment of the acetyl moiety to Cys112 (bond distance, 1.8 Å), indicating that the substrate was turned over by the enzyme to yield an initial product complex. This is direct evidence that Cys112 is the catalytic nucleophile. The acetyl oxygen makes hydrogen bonds to the backbone nitrogens of Gly306 (2.8 Å) and Cys112 (3.0 Å). These backbone nitrogens are ideal for stabilizing the oxyanion formed during the transition state of acetyl transfer. The same role can be suggested for the backbone nitrogens of Phe400 and Cys163 of FabF by structural analogy. FabH Ala113 has a slightly unfavorable torsion angle, which may be required to make Cys112 N available for the interaction. The acetyl methyl group occupies a hydrophobic pocket in the active site, formed by the side chains of Leu142, Phe157, Leu189, Leu205, and Phe87', which belongs to the other monomer (Fig. 5A). The van der Waals interactions between the acetyl methyl and Phe87' suggest that the dimer interface plays a critical role in determining the primer specificity of FabH.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   Substrate binding and structure of the active site. A, stereo view of the acetyl binding pocket in the active site. Atom colors are as defined as follows: carbon, yellow; nitrogen, blue; oxygen, red; and sulfur, green. The acetyl group is shown with red bonds, whereas the dashed lines indicate hydrogen bonds. Phe87 of the other monomer in the FabH dimer is labeled as Phe87' and is shown in magenta. For clarity, only the mercaptoethylamine group of CoA is shown, which is drawn with green bonds. B, electron density of the bound CoA molecule. Atom colors are as defined before, with the three phosphorous atoms in blue as well. The map is contoured at 1sigma . C, adenine binding site. Protein residues are in yellow bonds, and the CoA molecule is drawn in purple bonds. Carbon atoms are drawn in yellow, nitrogens in blue, oxygens in red, and phosphors in purple. The dashed lines denote hydrogen bonds.

Surprisingly, we found a CoA molecule bound in the acetyl-CoA complex, although the electron density is weak for parts of the molecule (Fig. 5B). Observing CoA in the crystal suggests that the reaction product has a notable FabH affinity. The bound CoA allows us to define the active site cavity, which is long (~15 Å) and narrow, ideal for fitting the pantetheine group of substrates in a more or less extended conformation. The adenine ring of CoA stacks between the side chains of Trp32 and Arg151 (Fig. 5C), a classical adenine binding mode. The Arg151 side chain also interacts with the ribose hydroxyl (3.4 Å) and phosphate (3.2 Å), whereas the N-cap dipole of helix Cb1 and Arg36 are involved in stabilizing the diphosphate. The pantetheine group interacts with the hydrophobic wall of the active site cavity, comprised of residues such as Ile156, Met207, Val212, Phe213, and Ile250. The pantothenate also forms a couple of hydrogen bonds (O9 to Asn247 ND2, 2.9 Å; N8 to Gly209 O, 3.1 Å) with the enzyme, but the beta -mercaptoethylamine tail of CoA is flexible, as indicated by the weak electron density and the lack of specific protein interactions. Cys112 is at the bottom of this cavity, with the acetyl carbon 3.9 Å away from the CoA sulfur atom (Fig. 5A).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

It has been shown that FabH can accept primers such as acetyl-, propionyl-, and butyryl-CoA, but not long chain acyl-CoA (7, 8). This is supported by our FabH structure, in which the primer binding pocket is indeed quite small (Fig. 5A). The acetyl methyl group takes up most of the space in this pocket and is within reasonable van der Waals distances to Leu142, Phe157, and Phe87'. It is possible to model an additional carbon pointing between the side chains of Leu189 and Phe157, suggesting a propionyl group can also fit. Adding yet another carbon appears to require side chain rearrangements, consistent with a much reduced efficiency for butyryl-CoA. This is in contrast to the FabF primer binding pocket that is much more extended and is the locus of binding of cerulenin (23). A helical segment of FabF (Phe133-Ile138) is found by structural analogy to play a role similar to FabH Phe87', suggesting the use of dimer interface as a conserved feature in condensing enzymes to modulate primer specificity. It is clear from structural inspection that cerulenin or a long acyl chain would not bind the FabH enzyme because the pocket is too small.

Although our acetyl-CoA structure turns out to be a product complex, the observed CoA provides a basis for modeling either of the FabH substrates. As indicated by the nature of the interactions, the mode of CoA binding should approximate that of the acetyl-CoA from adenine to most of the pantothenate. The observed flexible CoA tail is probably not an accurate representation of acetyl-CoA, but the substrate binding mode can be modeled with only a few free bond rotations. In such a model, this tail is probably in a more extended conformation. The hydrogen bonds between the acetyl carbonyl oxygen and the backbone nitrogens of Gly306 and Cys112 may guide the acetyl group into the active site, positioning it for nucleophilic attack by Cys112 (Fig. 6A). His244, 3.4 Å from Cys112, is in position to act as a general base and extract a proton from Cys112. Asn274 is too far (4.2 Å from Cys112) to assume this role. The side chain of Ser276 is 3.8 Å from Cys112, but its nature prohibits it from accepting a proton. The reaction likely goes through a tetrahedral intermediate, with the carbonyl group forming an oxyanion. The backbone nitrogens of Gly306 and Cys112 can stabilize this oxyanion. After the acetyl transfer to Cys112, His244 could replenish the CoA sulfur with a proton to produce a neutral CoA (Fig. 6A). In well-known examples such as serine proteases, catalytic residues can be superimposed regardless of large differences in the overall protein folding (26). However, His244 and its analogous residue in FabF (His303) are in different positions with respect to the catalytic cysteines (Fig. 4). This is most likely attributable to differences in the substrates, suggesting that the histidine may interact directly with substrates or intermediates in addition to its role as the catalytic base. The positional differences in the catalytic apparatus suggest that condensing enzymes are under stringent evolutionary pressure to recognize and process different substrates, another reason for their sequence divergence.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 6.   Proposed mechanism of the FabH reactions. A, schematic diagram of the acetylation reaction mechanism. Dotted lines indicate hydrogen bonds; thick arrows indicate attack or electron transfer directions. His244 extracts a proton from Cys112, which may then attack the carbonyl of acetyl-CoA. The tetrahedral intermediate is stabilized by backbone nitrogens of Gly306 and Cys112. His244 may donate a proton at the end of acetylation to form a neutral CoA. B, FabH surface charge distribution viewed toward the active site cavity. The figure was calculated with the acetyl-CoA complex structure after removing the bound CoA. Only the monomer was used, because the dimer interface is not in the area of interest. Red indicates negative potential, and blue indicates positive potential. The CoA molecule is shown to occupy the active site, with white for carbon atoms, blue for nitrogens, red for oxygens, yellow for phosphors, and green for the sulfur. C, proposed structural basis for the decarboxylation and condensation mechanisms. According to the mechanism (14), the carboxylic acid moiety probably binds His244, whereas the carbonyl group interacts with Asn274. The decarboxylation produces a carbanion, which resonates with an enol intermediate that is stabilized by Asn274. The nucleophilic attack from the carbanion to the enzyme-bound acetyl group leads to a tetrahedral intermediate and finally yields the product acetoacetyl-ACP.

The observed active site cavity appears to be the only access to Cys112 and, therefore, the possible binding cavity for the second substrate malonyl-ACP and the feedback inhibitor palmitoyl-ACP. Malonyl-ACP is a common substrate for many condensing enzymes. The phosphopantetheine group is linked to a serine of the ACP, which is an acidic protein of 78 residues (27). A region above the FabH cavity is positively charged and seems to be suitable for ACP binding (Fig. 6B). This region mainly includes two helices (Ca1 and Ca2) and contains several positively charged residues (Arg36, Arg40, Lys214, His222, Arg235, Arg249, Lys256, and Lys257). Binding of the prosthetic group of malonyl-ACP may be modeled based on the bound CoA. This is reasonable given that the acetylated FabH is known to react with ACP to produce acetyl-ACP (6), which is the reverse of the acetyl transfer reaction and a good indication that CoA and ACP can bind FabH similarly in the pantothenate region.

The acetyl transfer reaction is clearly a distinct step in the FabH reaction. A stepwise mechanism has also been proposed for decarboxylation and condensation (14, 28). FabH can catalyze the production of acetyl-ACP from butyryl-CoA and malonyl-ACP (8), further suggesting that decarboxylation need not occur in concert with condensation. The active sites are very similar between the apo and acetylated structures; only His244 shifts marginally (0.5 Å). However, it is known that malonyl-ACP only binds acetylated FabH but not the apo form of the enzyme (7, 8). This suggests that either the acetyl group interacts directly with the malonyl moiety, or the change of Cys112 electrostatic potential upon acetylation is important for the binding of this substrate. The former is unlikely because iodoacetamide can also induce the binding of the malonyl group (29). The latter is probably true because His244 is counterbalanced by Cys112 in apo FabH (Fig. 6A) but is available in acetylated FabH for a charged interaction with the malonyl carboxylic acid (Fig. 6C). His244 is the only potentially positively charged residue in the active site, which provides another reason for the proposed His244-carboxylic acid interaction during decarboxylation. In addition, His244 may stabilize the carbanion for the nucleophilic attack and donate a proton to Cys112 after condensation. Modeling clearly suggests that Asn274 forms a hydrogen bond with the malonyl carbonyl oxygen. Therefore, Asn274 may promote decarboxylation by general acid catalysis via stabilizing an enol intermediate (Fig. 6C) and hold the carbanion for nucleophilic attack in condensation. Other condensing enzymes use a histidine in that position, and the histidine is suitable to play these same roles of Asn274. Based on our structures, mutagenesis and biochemical experiments can be devised to test these models and their application in other condensing enzymes. The structure will also facilitate the structure-based design of novel antibiotic drugs against this important target.

    ACKNOWLEDGEMENTS

We thank the Advanced Photon Source Industrial Macromolecular Crystallography Association-Collaborative Access Team staff and the National Synchrotron Light Source X12C staff for assistance in data collection, Kathleen Maley for help in E. coli transformation, Dean McNulty for N-terminal sequence analysis, Dr. David Tew for insightful discussions, and Drs. Robert Daines, Bill Kingsbury, Marti Head, John Elliot, John Gleason, Christine Debouck, Jim Kane, and Glen Van Aller for encouragement.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and the structure factors (code 1D9B) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

Dagger To whom correspondence should be addressed. Tel.: 610-270-4589; Fax: 610-270-4091; E-mail: xiayang_qiu-1@sbphrd.com.

2 J. Lonsdale, unpublished data.

3 A. Konstandinidis, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ACP, acyl-carrier protein; FabH, beta -ketoacyl-ACP synthase III; FabF, beta -ketoacyl-ACP synthase II; r.m.s., root mean square.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Cronan, J. E., Jr., and Rock, C. O. (1996) in E. coli and Salmonella, Cellular and Molecular Biology (Neidhardt, F. C., ed) , pp. 612-638, ASM Press, Washington, D. C.
2. Magnuson, K., Jackowski, S., Rock, C. O., and Cronan, J. E. (1993) Microbiol. Rev. 57, 522-542[Abstract/Free Full Text]
3. Hopwood, D. A., and Sherman, D. H. (1990) Annu. Rev. Genet. 24, 37-66[CrossRef][Medline] [Order article via Infotrieve]
4. Cane, D. E., Walsh, C. T., and Khosla, C. (1998) Science 282, 63-68[Abstract/Free Full Text]
5. McDaniel, R., Thamchaipenet, A., Gustafsson, C., Fu, H., Betlach, M., and Ashley, G. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 1846-1851[Abstract/Free Full Text]
6. Tsay, J. T., Oh, W., Larson, T. J., Jakowski, S., and Rock, C. O. (1992) J. Biol. Chem. 267, 6807-6814[Abstract/Free Full Text]
7. Heath, R. J., and Rock, C. O. (1996) J. Biol. Chem. 271, 1833-1836[Abstract/Free Full Text]
8. Heath, R. J., and Rock, C. O. (1996) J. Biol. Chem. 271, 10996-11000[Abstract/Free Full Text]
9. Verwoert, I. I., van der Linden, K. H., Walsh, M. C., Nijkamp, H. J., and Stuitje, A. R. (1995) Plant Mol. Biol. 27, 875-876[CrossRef][Medline] [Order article via Infotrieve]
10. Han, L., Lobo, S., and Reynolds, K. A. (1998) J. Bacteriol. 180, 4481-4486[Abstract/Free Full Text]
11. Clough, R. C., Matthis, A. L., Barnum, S. R., and Jaworski, J. G. (1992) J. Biol. Chem. 267, 20992-20998[Abstract/Free Full Text]
12. Travis, J. (1994) Science 264, 360-362[Free Full Text]
13. Stinson, S. C. (1996) Chem. Eng. News 74, 75-100
14. Siggaard-Anderson, M. (1993) Protein Seq. Data Anal. 5, 325-335
15. Omura, S. (1979) Bacteriol. Rev. 40, 681-697
16. Terwilliger, T. C., and Berendzen, J. (1999) Acta Crystallogr. D 55, 849-861[CrossRef]
17. Brunger, A. T. (1993) X-PLOR Version 3.1, A System for X-ray Crystallography and NMR , Yale University Press, New Haven
18. Collaborative Computational Project Number 4. (1994) Acta Cryst. D 50, 760-763
19. McRee, D. E. (1993) Practical Protein Crystallography , Academic Press, San Diego
20. Kraulis, P. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef]
21. Nicholls, A., and Honig, B. H. (1991) J. Comp. Chem. 12, 435-445[CrossRef]
22. Huang, W., Jia, J., Edwards, P., Dehesh, K., Schneider, G., and Lindqvist, Y. (1998) EMBO J. 17, 1183-1191[CrossRef][Medline] [Order article via Infotrieve]
23. Moche, M., Schneider, G., Edwards, P., Dehesh, K., and Lindqvist, Y. (1999) J. Biol. Chem. 274, 6031-6034[Abstract/Free Full Text]
24. Mathieu, M., Zeelen, J. P., Pauptit, R. A., Erdmann, R., Kunau, W. H., and Wierenga, R. K. (1994) Structure 2, 797-808[Medline] [Order article via Infotrieve]
25. Mathieu, M., Modis, Y., Zeelen, J. P., Engel, C. K., Abagyan, R. A., Ahlberg, A., Rasmussen, B., Lamzin, V. S., Kunau, W. H., and Wierenga, R. K. (1997) J. Mol. Biol. 273, 714-728[CrossRef][Medline] [Order article via Infotrieve]
26. Qiu, X., Culp, J. S., DiLella, A. G., Hellmig, B., Hoog, S. S., Janson, C. A., Smith, W. W., and Abdel-Meguid, S. S. (1996) Nature 383, 275-279[CrossRef][Medline] [Order article via Infotrieve]
27. Mayo, K. H., and Prestegard, J. H. (1985) Biochemistry 24, 7834-7838[CrossRef][Medline] [Order article via Infotrieve]
28. Clark, J. D., O'Keefe, S. J., and Knowles, J. R. (1988) Biochemistry 27, 5961-5971[CrossRef][Medline] [Order article via Infotrieve]
29. Kresze, G. B., Steber, L., Oesterhelt, D., and Lynen, F. (1977) Eur. J. Biochem. 79, 191-199[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
K. Fukuma, E. D. Neuls, J. M. Ryberg, D.-Y. Suh, and U. Sankawa
Mutational Analysis of Conserved Outer Sphere Arginine Residues of Chalcone Synthase
J. Biochem., December 1, 2007; 142(6): 731 - 739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-M. Zhang, J. Hurlbert, S. W. White, and C. O. Rock
Roles of the Active Site Water, Histidine 303, and Phenylalanine 396 in the Catalytic Mechanism of the Elongation Condensing Enzyme of Streptococcus pneumoniae
J. Biol. Chem., June 23, 2006; 281(25): 17390 - 17399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Brown, S. Sridharan, L. Kremer, S. Lindenberg, L. G. Dover, J. C. Sacchettini, and G. S. Besra
Probing the Mechanism of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Synthase III mtFabH: FACTORS INFLUENCING CATALYSIS AND SUBSTRATE SPECIFICITY
J. Biol. Chem., September 16, 2005; 280(37): 32539 - 32547.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
X. Qiu, A. E. Choudhry, C. A. Janson, M. Grooms, R. A. Daines, J. T. Lonsdale, and S. S. Khandekar
Crystal structure and substrate specificity of the {beta}-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus
Protein Sci., August 1, 2005; 14(8): 2087 - 2094.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
Y. Li, G. Florova, and K. A. Reynolds
Alteration of the Fatty Acid Profile of Streptomyces coelicolor by Replacement of the Initiation Enzyme 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH)
J. Bacteriol., June 1, 2005; 187(11): 3795 - 3799.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Theisen, I. Misra, D. Saadat, N. Campobasso, H. M. Miziorko, and D. H. T. Harrison
From the Cover: 3-hydroxy-3-methylglutaryl-CoA synthase intermediate complex observed in "real-time"
PNAS, November 23, 2004; 101(47): 16442 - 16447.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Campobasso, M. Patel, I. E. Wilding, H. Kallender, M. Rosenberg, and M. N. Gwynn
Staphylococcus aureus 3-Hydroxy-3-methylglutaryl-CoA Synthase: CRYSTAL STRUCTURE AND MECHANISM
J. Biol. Chem., October 22, 2004; 279(43): 44883 - 44888.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Austin, M. Izumikawa, M. E. Bowman, D. W. Udwary, J.-L. Ferrer, B. S. Moore, and J. P. Noel
Crystal Structure of a Bacterial Type III Polyketide Synthase and Enzymatic Control of Reactive Polyketide Intermediates
J. Biol. Chem., October 22, 2004; 279(43): 45162 - 45174.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
X. He, A. M. Reeve, U. R. Desai, G. E. Kellogg, and K. A. Reynolds
1,2-Dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH)
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3093 - 3102.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
C. T. Nomura, K. Taguchi, S. Taguchi, and Y. Doi
Coexpression of Genetically Engineered 3-Ketoacyl-ACP Synthase III (fabH) and Polyhydroxyalkanoate Synthase (phaC) Genes Leads to Short-Chain-Length-Medium-Chain-Length Polyhydroxyalkanoate Copolymer Production from Glucose in Escherichia coli JM109
Appl. Envir. Microbiol., February 1, 2004; 70(2): 999 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
A. C. Price, C. O. Rock, and S. W. White
The 1.3-Angstrom-Resolution Crystal Structure of {beta}-Ketoacyl-Acyl Carrier Protein Synthase II from Streptococcus pneumoniae
J. Bacteriol., July 15, 2003; 185(14): 4136 - 4143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Misra, C.-Z. Wang, and H. M. Miziorko
The Influence of Conserved Aromatic Residues in 3-Hydroxy-3-methylglutaryl-CoA Synthase
J. Biol. Chem., July 11, 2003; 278(29): 26443 - 26449.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
B. Nowak-Thompson, P. E. Hammer, D. S. Hill, J. Stafford, N. Torkewitz, T. D. Gaffney, S. T. Lam, I. Molnar, and J. M. Ligon
2,5-Dialkylresorcinol Biosynthesis in Pseudomonas aurantiaca: Novel Head-to-Head Condensation of Two Fatty Acid-Derived Precursors
J. Bacteriol., February 1, 2003; 185(3): 860 - 869.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
X. He and K. A. Reynolds
Purification, Characterization, and Identification of Novel Inhibitors of the {beta}-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Funa, Y. Ohnishi, Y. Ebizuka, and S. Horinouchi
Properties and Substrate Specificity of RppA, a Chalcone Synthase-related Polyketide Synthase in Streptomyces griseus
J. Biol. Chem., February 8, 2002; 277(7): 4628 - 4635.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Atanassov, L. Pezennec, J. d'Alayer, G. Grollier, B. Picard, and J.-L. Fauchere
Novel Antigens of Helicobacter pylori Correspond to Ulcer-Related Antibody Pattern of Sera from Infected Patients
J. Clin. Microbiol., February 1, 2002; 40(2): 547 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
G. E. Schujman, K.-H. Choi, S. Altabe, C. O. Rock, and D. de Mendoza
Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance
J. Bacteriol., May 15, 2001; 183(10): 3032 - 3040.
[Abstract] [Full Text]


Home page
J. Bacteriol.Home page
N. Smirnova and K. A. Reynolds
Engineered Fatty Acid Biosynthesis in Streptomyces by Altered Catalytic Function of {beta}-Ketoacyl-Acyl Carrier Protein Synthase III
J. Bacteriol., April 1, 2001; 183(7): 2335 - 2342.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K.-H. Choi, L. Kremer, G. S. Besra, and C. O. Rock
Identification and Substrate Specificity of beta -Ketoacyl (Acyl Carrier Protein) Synthase III (mtFabH) from Mycobacterium tuberculosis
J. Biol. Chem., September 1, 2000; 275(36): 28201 - 28207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Price, K.-H. Choi, R. J. Heath, Z. Li, S. W. White, and C. O. Rock
Inhibition of beta -Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin. STRUCTURE AND MECHANISM
J. Biol. Chem., February 23, 2001; 276(9): 6551 - 6559.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-M. Zhang, M. S. Rao, R. J. Heath, A. C. Price, A. J. Olson, C. O. Rock, and S. W. White
Identification and Analysis of the Acyl Carrier Protein (ACP) Docking Site on beta -Ketoacyl-ACP Synthase III
J. Biol. Chem., March 9, 2001; 276(11): 8231 - 8238.
[Abstrac